Miami CEO
March 11 - 13, 2026
The Ritz-Carlton, Key Biscayne, Miami
Miami CEO convenes an intimate gathering of pharma and biotech leaders for top-tier networking and compelling discussion in a relaxed and engaged off-the-record environment at The Ritz-Carlton Key Biscayne. The forum hosts leaders in the industry for a mixture of discussion panels and highly valuable networking events in a relaxed and engaged environment. In addition to panel discussions and fireside chats, Miami CEO hosts top-rate closed-door networking events including sunset cocktails and dinner over the Miami harbor at the Key Biscayne Yacht Club. The meeting opens with a private reception at the Ritz Carlton on Wednesday evening, March 11.
Featured Participants
Leading Researchers & Industry Pioneers
Renowned BioPharma CEOs
Blue-Chip Investors
BioPharma R&D Leaders
BioPharma BD & Strategy Leaders
Highlights from Miami CEO
View highlights from the 2025 Miami CEO and hear what makes the meeting so unique. Watch footage and hear testimonials from industry leaders at Miami CEO, including: Brent Saunders (Chair & CEO, Bausch + Lomb), Levi Garraway (CMO, Roche Genentech), Bill Mezzanotte (Global Head, R&D, CSL), Jeremy Levin (CEO, Ovid Therapeutics), Julie Gerberding (former Director, CDC), Greg Verdine (CEO, LifeMine Therapeutics), Jeff Aronin (CEO, Paragon Biosciences), and more.
Testimonials
Julie Gerberding
former Director, CDC
CEO, Foundation for the NIH
“The topics really addressed the crazy environment in which we're all operating and brought all the dimensions together to focus the biotech ecosystem on not only what the problems are, but what the opportunities are, and I think all of us are leaving with a little bit more hope.”
Agenda
6:30 - 9:30 pm
Welcome Reception for meeting participants (significant others welcome) | Ritz Carlton Key Biscayne North Pool
Wednesday, March 11
Thursday, March 12
7:00 am | Networking Breakfast | Ritz Carlton Veranda
7:30 am | Welcome & Opening Remarks | Ritz Carlton Ballroom
Christoph Westphal, General Partner, Longwood Fund
8:00 am | Biopharma Pipeline Sourcing
Markus Haeberlein, EVP, Discovery Science, Parabilis Medicines
Bill Mezzanotte, EVP, R&D, CSL
Paris Panayiotopoulos, Senior Managing Director, Blackstone
Moderator: Sekhar Naik, CEO, MResult
8:30 am | Pipeline Prioritization
Meg Alexander, CEO, Ovid Therapeutics
Greg Frost, CEO, Exuma Biotech
Rachel Humphrey, CEO, Normunity
Brent Warner, CEO, Protego
Moderator: Paul Peter Tak, CEO, Candel Therapeutics
9:00 am | Navigating the Regulatory Landscape
Ned Braunstein, EVP, Regulatory Affairs & Global Patient Safety, Regeneron
Shalabh Gupta, CEO, Unicycive
Chrystal Louis, CMO, TScan Therapeutics
Moderator: Vikram Karnani, CEO, Collegium Pharmaceutical
9:30 am | Translating Science into Medicine
Anish Bhatnagar, CEO, Soleno Therapeutics
Bill Hait, Chief Scientific Advisor, AACR; former CMO, Johnson & Johnson
Jeremy Levin, Chair, Ovid Therapeutics
Sondra Neale Smyrnios, SVP, Clinical & Technical Operations, Newleos
10:00 am | Ecosystem of External Innovation
Debbie Drane, Head, BD, Therapeutic Areas, CSL
Mike McCully, President & COO, Syndeio Biosciences
David Redfern, President, Corporate Development, GSK
Daniel Teper, CEO, Naya Therapeutics
Moderator: Brian McVeigh, CEO, Code Bio
10:30 am | Global Markets: Working Across Borders
Stewart Campbell, CEO, Novita Pharmaceuticals
Iain Kilty, CEO, Sitryx
Jing Li, CEO, VelaVigo
Bart van Rhijn, CFO & CBO, Nanobiotix
Moderator: Pascal Touchon, Operating Partner, Jeito Capital
11:00 am | Fireside Chat
Pablo Cagnoni, President, Head, R&D, Incyte
Brent Saunders, CEO, Bausch + Lomb
Moderator: Christoph Westphal, General Partner, Longwood Fund
11:30 am - 2:30 pm | Private luncheon on the beach (significant others welcome)
6:00 pm | Sunset cocktails and private dinner | Key Biscayne Yacht Club
Friday, March 13
7:00 am | Networking Breakfast
7:45 am | Adapting to Funding Environment Constraints
Brant Binder, President, Bonito Biosciences
Eric Murphy, CEO, Sidewinder
Luis Peña, CEO, Evommune
Chirag Surti, Executive Director, Morgan Stanley
Moderator: Al Beardsley, CEO, Cirius Therapeutics
8:15 am | Accelerating Drug Development
Gavin MacBeath, CEO, TScan Therapeutics
Frank Nestle, Partner & CEO, Deerfield Discovery and Development
Sam Waksal, CEO, Graviton Bio
Lai Wang, President, Global Head, R&D, BeOne Medicines
Moderator: Zhen Su, CEO, Marengo Therapeutics
8:45 am | Leveraging an Effective Board
Meeta Chatterjee, former Chief Strategy Officer, Sun Pharma
Jason Fuller, Partner, Deerfield
RJ Kirk, Chair, Precigen
Amanda Wagner, CEO, Immunitas
Moderator: Jak Knowles, CEO, Thalassa Bio
9:15 am | Fireside Chat
Chris Boshoff, CSO & President, R&D, Pfizer
Rob Califf, former Commissioner, FDA
Co-Moderators: Sekhar Naik, CEO, MResult
Christoph Westphal, General Partner, Longwood Fund
9:35 am | Accelerating the Path to Patient Care
Raza Bokhari, CEO, Medicus Pharma
Raj Dattani, Head, Development, Relation Therapeutics
Julie Gerberding, CEO, Foundation for the NIH; former Director, CDC
Gilmore O’Neill, CEO, Editas Medicine
Moderator: Jon Cohen, Head, Life Sciences Go-To-Market, ServiceNow
10:05 am | Recruiting Talent, Developing Culture
Bobby Gaspar, CEO, Orchard Therapeutics
Anna Kazanchyan, CEO, Saghmos Therapeutics
Neil McFarlane, CEO, Zevra Therapeutics
Paul Sekhri, CEO, vTv Therapeutics
10:35 am | The Evolving Deal-Making Landscape
Alan Ginsberg, Head, Global Licensing & BD, New TAs, EMD Serono
David Meek, CEO, Genetix Biotherapeutics; former CEO, Ipsen
Vikram Ranade, CBO, Dyne Therapeutics
Moderator: Konstantina Katcheves, Chief Business & Chief Strategy Officer, Acadia Pharmaceuticals
11:05 am | Investment Outlook
Michael Aberman, General Partner, Regeneron Ventures
Nessan Bermingham, Operating Partner, Khosla Ventures
Benj Garrett, Managing Director, Stifel
Claudine Prowse, Venture Partner, JPM Private Capital
Moderator: Vikas Goyal, Partner, Longwood Fund
11:30 pm | Mimosa send-off | Ritz Carlton Patio
Miami CEO is hosted at The Ritz-Carlton Key Biscayne, Miami.
A limited number of hotel rooms are held at the meeting venue.
Please make reservations as soon as possible to ensure your spot.
Book online: www.ritzcarlton.com/en/hotels/miami/key-biscayne
Call reservations: 800-241-3333
The Ritz-Carlton Key Biscayne, Miami is located approximately 30 minutes from Miami International Airport.
Venue
Speaking Faculty
Companies Represented
at Previous Miami CEO
23andMe
8 Prime
Abzena
Adimab
Affimed
Affini-T
Agios
Aitia
Akamis Bio
ALAFIA
Alexandria Real Estate Equities
Alliant
AlloVir
Alloy Therapeutics
Altesa Biosciences
AltruBio
American Cancer Society
ANeuroTech
Apellis Pharmaceuticals
Apogee Therapeutics
ArsenalBio
Ashvattha Therapeutics
Astellas
Bausch + Lomb
Be Bio
BenchSci
BFlexion
BIO (Biotechnology Industry Organization)
bit.bio
Bitterroot Bio
Blackstone Life Science
Bluejay Therapeutics
BlueRock Therapeutics
Bonito Biosciences
Boston Properties
Boundless Bio
Braeburn
BreakBio
Cadrenal Therapeutics
Cain Global Partners
Cambrian Biopharma
Candel Therapeutics
Carbon Biosciences
Caris Life Sciences
Caszyme
Catalent
Catalyst Advisors
Cerevance
Cirius Therapeutics
CNS Pharmaceuticals
Code Bio
Collegium Pharmaceutical
Corner Therapeutics
CSL
CureDuchenne
Curie.Bio
Cytiva
Danaher Corporation
Deerfield Management
Define Ventures
Deka Biosciences
Delta Life Sciences
Dualitas
Dyne Therapeutics
Editas Medicine
Eledon Pharmaceuticals
EMD Serono
Engrail Therapeutics
Entact Bio
Eratos Therapeutics
Evommune
Exelixis
Exuma Biotech
Eyepoint Pharmaceuticals
Flagship Pioneering
Foley Hoag
Foresee Pharmaceuticals
Formation Bio
Foundation for the NIH
Founders Fund
Fractyl
Gallop Oncology
Generian
Genetix Biotherapeutics
GHO Capital Partners
Gilgamesh Pharmaceutical
Ginkgo Bioworks
GlycoEra
Gradalis
Graviton Bio
H1
Hansa Biopharma
Healthcare Royalty Partners
HealthQuest Capital
Herophilus
Herringbone & Brass
IGI
Immunitas
Immunoprecise Antibodies
Intrexon Corporation
Ipsen
IQVIA
Ironwood Pharmaceuticals
Jeito Capital
Johnson & Johnson
JPM Private Capital
Karuna Therapeutics
Karyopharm Therapeutics
Klick
Lilly
Longwood Fund
Lumanity
Lumen Bioscience
Lundbeck
Lupin
Mammoth
Marengo Therapeutics
Mass General Brigham
MassBio
Matrix Capital
Medable
Medicilon
Merrill Lynch
MetroBiotech
Mimetic Medicines
Mintz
Mongoose Bio
Morphoceuticals
MPM BioImpact
MResult
Multiple Myeloma Research Foundation
Myris Therapeutics
Nan Fung
NanoCell Therapeutics
NAYA Therapeutics
Neurocentria
Neurocrine Biosciences
New Enterprise Associates
Normunity
Novartis
Nvelop Therapeutics
Ochre Bio
Octant
Odgers Berndtson
Opus Genetics
Orano Med
Origenis GmbH
Orna Therapeutics
Ovid Therapeutics
Parabilis Medicines
Paragon Biosciences
Parexel
Pfizer
Phanes Therapeutics
Pivotal Life Sciences
Portal Instruments
Precede Biosciences
Precision BioSciences
Precision for Medicine
Premji Invest
PriveBio
ProFound Therapeutics
Project Prometheus
ProMIS Neurosciences
Protego Biopharma
Pulmocide
Pyxis Oncology
Qilu Pharmaceutical
Quanterix
QurAlis
Radiant Biotherapeutics
Rallybio
Rectify Pharmaceuticals
Recursion
Regeneron
Regeneron Ventures
REGENXBIO
Replicor
Roche
Roivant Sciences
Royalty Pharma
Saghmos Therapeutics
Sarepta Therapeutics
SELLAS Life Sciences Group
Skye Bioscience
Sofinnova
Solu Therapeutics
Spirovant Sciences
Starton Therapeutics
Stifel Financial Corporation
Stipple Bio
Summit Therapeutics
Supernus Pharmaceutical
Syndeio Biosciences
Tane Pharmaceuticals, Inc.
Taron Solutions
Tolerance Bio
TPG
TRexBio
Trio Pharmaceuticals
TScan Therapeutics
Twain Therapeutics
Unicycive
Unipr
Uniquity Bio
University Health Network
University of Miami
VectorY Therapeutics
Verastem
Vertex Ventures
Verve Therapeutics
VidaVinci
Viking Global Investors
Volastra Therapeutics
Vor Biopharma
Voyager Therapeutics
Weaver
WuXi AppTec
Xilio Therapeutics
XyloCor
Zai Lab
ZRG Partners
